BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Sao_Paulo
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0300
TZNAME:-03
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Denver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20240310T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20241103T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20250309T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20251102T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20260308T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20261101T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Tokyo
BEGIN:STANDARD
TZOFFSETFROM:+0900
TZOFFSETTO:+0900
TZNAME:JST
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Rome
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Athens
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Africa/Cairo
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240425T220000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241031T210000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250424T220000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251030T210000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20260423T220000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20261029T210000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Hong_Kong
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:HKT
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250306T100000
DTEND;TZID=Europe/Brussels:20250306T113000
DTSTAMP:20260404T084101
CREATED:20250223T120647Z
LAST-MODIFIED:20250608T082215Z
UID:10000151-1741255200-1741260600@oncodaily.com
SUMMARY:The EUHPP Live Webinar Series 3
DESCRIPTION:The EUHPP Live Webinar Series 3 will be held on March 6th\, 2025\, Virtually. \nThe EUHPP Live Webinar Series 3 will focus on the essential steps that Member States need to take to implement the European Health Data Space (EHDS). This session will delve into the roles of digital health authorities and health data access bodies\, providing actionable guidance on building the necessary infrastructure\, establishing governance frameworks\, and ensuring operational readiness. \nParticipants will gain a clear understanding of their responsibilities in the implementation process and the resources available to assist them. The presentation\, titled “Implementation and Governance – Who Does What?”\, aims to equip stakeholders with practical knowledge for driving the successful roll-out of the EHDS. \nRegistration is open for the event.
URL:https://oncodaily.com/event/247122
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/02/download-12-1.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250306T000000
DTEND;TZID=America/Halifax:20250309T000000
DTSTAMP:20260404T084101
CREATED:20241205T185124Z
LAST-MODIFIED:20250608T085949Z
UID:10000092-1741219200-1741478400@oncodaily.com
SUMMARY:SACT 2025
DESCRIPTION:SACT 2025 will be held at Mumbai\, India from March 6-9\, 2025. \nThe SACT 2025 Conference will feature various key programs designed to advance knowledge and practices in cancer care and treatment. The Translational Pathway Program will focus on the latest research and breakthroughs in translational oncology\, bridging basic science with clinical application. The Clinical Pathway Program will delve into the practical aspects of cancer treatment\, offering insights on optimizing clinical practices and patient care. \nThe Roundtable Sessions will provide an interactive platform for participants to engage in in-depth discussions on critical topics in oncology\, fostering collaboration and knowledge exchange. The Abstracts Session will showcase cutting-edge research\, allowing researchers to present their findings and receive feedback from their peers. Global Showcases will highlight innovative approaches to cancer treatment and care from across the globe\, providing diverse perspectives and solutions.
URL:https://oncodaily.com/event/198376
LOCATION:Tata Memorial Centre\, Dr. E Borges Road\, Parel\, Mumbai\, Maharashtra\, Mumbai\, 400012\, India
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/Untitled-154.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250305T180000
DTEND;TZID=America/Halifax:20250305T190000
DTSTAMP:20260404T084101
CREATED:20250208T111251Z
LAST-MODIFIED:20250608T085957Z
UID:10000131-1741197600-1741201200@oncodaily.com
SUMMARY:People\, places\, and platforms that support a cancer patient’s journey by SPCC
DESCRIPTION:People\, places\, and platforms that support a cancer patient’s journey by SPCC will be held at March 5\, 2025\, Virtually. \nThis conference focuses on the various people\, places\, and platforms that support a cancer patient’s journey. It highlights the importance of a comprehensive support network that goes beyond medical treatment. Compassionate healthcare professionals\, supportive family members\, specialized medical centers\, and digital innovations all play a vital role in providing comfort\, guidance\, and resources. \nThese interconnected elements help empower patients to face their cancer journey with resilience and strength. The session will feature speakers Aleksandra Filipovic\, Steve Bierman\, and Alejandro Piris\, who will share their insights on how these diverse forms of support contribute to improving patient outcomes.
URL:https://oncodaily.com/event/239077
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/02/Webinar_05_Mar_Banner_Newsletter.jpg
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20250303T110000
DTEND;TZID=Europe/Paris:20250305T160000
DTSTAMP:20260404T084101
CREATED:20241007T184831Z
LAST-MODIFIED:20250608T090003Z
UID:10000017-1740999600-1741190400@oncodaily.com
SUMMARY:ESMO Targeted Anticancer Therapies Congress 2025
DESCRIPTION:The ESMO Targeted Anticancer Therapies Congress 2025\, will be held from March 3-5 in Paris\, France. \nIt is organized by the European Society for Medical Oncology. This essential multi-stakeholder forum brings together researchers\, industry partners\, investors\, and regulatory bodies\, creating a unique opportunity for professionals involved in the development of new anticancer drugs. \nThis is a fantastic chance to connect in Paris\, share the latest data\, foster collaboration\, and tackle the challenges we face in accelerating the path from bench to bedside for the benefit of our patients. Don’t miss out on being part of this important conversation! \nRegister here. \nFind more information featuring ESMO at OncoDaily.com.
URL:https://oncodaily.com/event/159925
LOCATION:Paris Marriott Rive Gauche Hotel\, 17\, Boulevard St. Jacques\, Paris\, 75014\, France
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/ESMO.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250301T000000
DTEND;TZID=America/Halifax:20250305T000000
DTSTAMP:20260404T084101
CREATED:20241208T200313Z
LAST-MODIFIED:20250608T090016Z
UID:10000097-1740787200-1741132800@oncodaily.com
SUMMARY:The Nordic Radiotherapy Diploma Programme (NORTHDIP) for Clinical Oncologists by ESTRO
DESCRIPTION:The Nordic Radiotherapy Diploma Programme (NORTHDIP) for Clinical Oncologists by ESTRO will be going on for two years from March 2025 to November 2026. \nThe Nordic Radiotherapy Diploma Programme (NORTHDIP) is a two-year advanced education initiative designed for clinical oncologists across the Nordic countries: Denmark\, Iceland\, Finland\, Norway\, and Sweden. The programme addresses the need for supplementary radiotherapy training for oncologists who specialize in radiotherapy after their clinical oncology education. \nThe goal of NORTHDIP is to enhance radiotherapy skills and foster collaboration among Nordic clinical oncologists\, ultimately advancing expertise in the region and promoting collaborative research and development in radiotherapy. \nThe programme’s content is aligned with ESTRO’s core curriculum for radiation oncologists and covers a variety of advanced topics: \n\nSweden 2024: Advanced radiophysics\, dose planning\, organs-at-risk constraints\, and advanced technologies.\nNorway 2025: Radiobiology\, benign diseases\, and palliative care.\nFinland 2025: Reirradiation\, stereotactic radiotherapy\, and BNCT (Boron Neutron Capture Therapy).\nDenmark 2026: Adaptive radiotherapy and imaging (CBCT\, dual-energy CT\, PET-CT\, MRI)\, including the integration of proton and MR-Linac therapy.\nIceland 2026: Nordic research protocols\, including the design of clinical trials for collaborative Nordic implementation and shared patient recruitment.
URL:https://oncodaily.com/event/200355
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/11/IMG_7006.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Sao_Paulo:20250228T130000
DTEND;TZID=America/Sao_Paulo:20250302T160000
DTSTAMP:20260404T084101
CREATED:20250205T174409Z
LAST-MODIFIED:20250608T090024Z
UID:10000122-1740747600-1740931200@oncodaily.com
SUMMARY:14th Novi Sad Oncology Congress
DESCRIPTION:14th Novi Sad Oncology Congress will be held from February 28th to March 2nd. \nThe upcoming conference will focus on key oncology topics\, including improving outcomes for breast cancer patients\, advancements in immunotherapy\, and optimal treatment strategies for lung cancer. Sessions will cover the role of ctDNA in breast cancer treatment\, the influence of modern perioperative therapy on surgery\, and personalized approaches in treating stage IV NSCLC. \nA dedicated session on lung cancer will explore optimal peri-operative treatment and individualized care strategies. The conference will also feature discussions on immune-related toxicities\, the role of vaccines in cancer treatment\, and the latest developments in CAR-T therapy\, bispecific antibodies\, and checkpoint inhibitors for lymphoma. \nRegistration is open. \nSee the Program of the Event.
URL:https://oncodaily.com/event/232785
LOCATION:University of Novi Sad\, DR. ZORANA DJINDJICA 1\, NOVI SAD\, Juzno-Backi PAK\, Novi Sad\, 402905\, Serbia
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/01/1737530507548-e1737917968962.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250227T153000
DTEND;TZID=Europe/Brussels:20250227T170000
DTSTAMP:20260404T084101
CREATED:20250223T115705Z
LAST-MODIFIED:20250608T090033Z
UID:10000150-1740670200-1740675600@oncodaily.com
SUMMARY:EUHPP Live Webinar Series 2
DESCRIPTION:EUHPP Live Webinar Series 2 will be held at February 27th\, 2025\, Virtually. \nDuring The EUHPP Live Webinar participants will explore how the European Health Data Space (EHDS) supports the secondary use of health data for purposes such as research\, innovation\, and policymaking. The event aims to provide valuable guidance on how to locate relevant health datasets\, apply for data access permits\, and ensure compliance with rigorous data protection safeguards. \nThis webinar is designed for stakeholders involved in health data access and usage\, offering practical insights and actionable takeaways on how to leverage health data responsibly and effectively. The presentation will focus on the secondary use of health data and is organized by Unit C1 – Digital Health\, DG SANT. This session promises to be an essential resource for those involved in or interested in the evolving landscape of health data management in Europe. \nRegistration is open for the event.
URL:https://oncodaily.com/event/247114
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/02/download-11-1.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20250227T093000
DTEND;TZID=Europe/Madrid:20250228T193000
DTSTAMP:20260404T084101
CREATED:20250208T191033Z
LAST-MODIFIED:20250608T090044Z
UID:10000128-1740648600-1740771000@oncodaily.com
SUMMARY:SOHO Spain 2025
DESCRIPTION:SOHO Spain 2025 will be held from February 27-28\, 2025 at Madrid\, Spain. \nThe SOHO Spain 2025 conference\, organized by the Society of Hematologic Oncology (SOHO)\, is a global event dedicated to clinicians\, research scientists\, and healthcare professionals specializing in the research and treatment of hematologic malignancies. Established in 2012\, SOHO’s mission is to accelerate research and education through the exchange of scientific information. With nearly 9\,500 members from 110 countries\, the society focuses on promoting research\, education\, clinical studies\, and optimal patient care across various hematologic disorders. \nThe conference will feature general sessions on key topics such as Acute Lymphoblastic Leukemia\, Acute Myeloid Leukemia\, Multiple Myeloma\, and Chronic Lymphocytic Leukemia\, among others. Notable directors for the event include Dr. Guillermo García-Manero from the University of Texas MD Anderson Cancer Center and Dr. Adolfo de la Fuente Burguera from MD Anderson Cancer Center Madrid – Hospiten\, Spain. This event provides a platform for sharing cutting-edge research\, advancing clinical practices\, and fostering collaboration in the fight against hematologic malignancies. \nThe Registration opens on February 20th.
URL:https://oncodaily.com/event/236758
LOCATION:Madrid\, Madrid\, Spain
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/02/IMG_7932.jpg
ORGANIZER;CN="Society of Hematologic Oncology":MAILTO:admin@isoho.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Denver:20250223T153000
DTEND;TZID=America/Denver:20250226T143000
DTSTAMP:20260404T084101
CREATED:20241008T184456Z
LAST-MODIFIED:20250608T090054Z
UID:10000022-1740324600-1740580200@oncodaily.com
SUMMARY:AACR IO Conference 2025
DESCRIPTION:The AACR IO 2025 will be held at the JW Marriott Los Angeles\, on February 23-26. It is organized by the American Association for Cancer Research. \nThis conference will explore the latest in immunology\, inflammation\, and cancer immunotherapies\, including IO drugs\, vaccines\, and cellular therapies. \nWith a program designed for everyone—from basic scientists to clinical investigators—attendees can expect keynote lectures\, symposia\, educational sessions\, and poster presentations. Highlights include late-breaking clinical trial sessions showcasing new treatments and combinations that could change cancer care. \nDon’t miss this opportunity to connect with experts and discover the cutting-edge advancements in the field. Register here. \nFind more information about the AACR at OncoDaily.com.
URL:https://oncodaily.com/event/160776
LOCATION:JW Marriott\, 900 W Olympic Blvd\, Los Angeles\, CA\, 90015\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/Untitled-24.jpg
ORGANIZER;CN="American Association for Cancer Research":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Tokyo:20250222T080000
DTEND;TZID=Asia/Tokyo:20250223T173000
DTSTAMP:20260404T084101
CREATED:20250201T193237Z
LAST-MODIFIED:20250608T090103Z
UID:10000127-1740211200-1740331800@oncodaily.com
SUMMARY:The Highlights of ASH in Asia-Pacific
DESCRIPTION:The Highlights of ASH in Asia-Pacific\, taking place on February 22-23\, 2025\, at PACIFICO Yokohama in Japan\, will offer a comprehensive overview of significant updates in clinical and translational hematologic research. \nThis two-day event will cover the most influential research presented at the latest American Society of Hematology (ASH) annual meeting\, offering a unique opportunity for attendees to learn how the latest scientific discoveries can directly impact the study and practice of hematology. The event aims to bridge the gap between research advancements and their translation into cutting-edge patient care. \nThe program will be co-chaired by leading experts in the field\, including Dr. Akifumi Takaori-Kondo and Dr. Kinuko Mitani from the Japanese Society of Hematology\, along with Dr. Jonathan Kaufman and Dr. Jia Ruan from the American Society of Hematology. Attendees will gain valuable insights into both malignant and non-malignant hematology and engage in discussions with the world’s leading hematology professionals. This event presents a premier opportunity for learning and collaboration within the field. \nRegistration is open!
URL:https://oncodaily.com/event/236742
LOCATION:PACIFICO Yokohama\, 1 Chome-1-1 Minatomirai\, Nishi Ward\, Yokohama\, Kanagawa\, 220-0012\, Japan
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/02/ASH-HOA-2025-Social-Posts-PARTNER-AP-FB-TW-1200x630-1.jpg
ORGANIZER;CN="American Society of Hematology":MAILTO:customerservice@hematology.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Rome:20250220T000000
DTEND;TZID=Europe/Rome:20250223T000000
DTSTAMP:20260404T084101
CREATED:20241205T124525Z
LAST-MODIFIED:20250608T090112Z
UID:10000090-1740009600-1740268800@oncodaily.com
SUMMARY:ESGO 2025
DESCRIPTION:The ESGO 26th European Gynaecological Oncology Congress\, taking place from February 20-23\, 2025\, in Rome\, Italy\, promises to be an exceptional educational event for those involved in the field of gynaecological oncology. The congress will feature over 50 scientific sessions\, highlighting the latest advancements in medical and scientific research\, treatment approaches\, and care strategies for gynaecological cancers. These sessions will be delivered by world-renowned experts\, offering attendees an invaluable opportunity to stay at the forefront of the field. \nUnder the leadership of ESGO President Prof. Anna Fagotti and Congress Local Chair Prof. Isabelle Ray-Coquard\, the event will present a comprehensive and inspiring programme aimed at advancing both knowledge and clinical practice. The congress is expected to foster collaboration\, innovation\, and a shared commitment to improving outcomes for patients with gynaecological cancers. Save the date for this significant gathering in Rome to engage with cutting-edge research and network with leaders in the field. \nThe Registration is Open until February 14th.
URL:https://oncodaily.com/event/197956
LOCATION:Rome Convention Center La Nuvola\, Piazza J.F. Kennedy - 00144 Rome\, Rome\, Italy
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/GIdx7CAWwAAddVs.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250219T120000
DTEND;TZID=America/Halifax:20250221T133000
DTSTAMP:20260404T084101
CREATED:20241218T180719Z
LAST-MODIFIED:20250608T090128Z
UID:10000108-1739966400-1740144600@oncodaily.com
SUMMARY:TRCCC 2025
DESCRIPTION:TRCCC 2025 will be held on February 19-21\, 2025\, at the Seven Springs Mountain Resort in Champion\, PA. \nThis event will serve as a premier gathering for cancer researchers\, clinicians\, and industry professionals\, fostering collaboration and innovation in the field of cancer research. The TRCCC Annual Meeting is a unique opportunity for attendees to engage in discussions around cutting-edge discoveries\, emerging therapies\, and the latest advancements in translational oncology. \nThe theme of this year’s meeting will focus on accelerating the translation of basic scientific discoveries into clinical applications. With a diverse range of presentations\, panel discussions\, and networking opportunities\, the event will cover the latest research in areas such as immunotherapy\, precision medicine\, targeted therapies\, and novel treatment approaches. The TRCCC Annual Meeting is designed to provide a collaborative environment for sharing ideas and forging new partnerships\, helping to bridge the gap between laboratory discoveries and real-world clinical applications. \nAbstract Submission Deadline is December 18th\, 2024. \nRegistration Deadline is January 15\, 2025.
URL:https://oncodaily.com/event/208205
LOCATION:Seven Springs Mountain Resort\, Champion\, PA\, 777 Water Wheel Dr\, Champion\, PA\, Champion\, 15622\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/Untitled-11-4.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250217T160000
DTEND;TZID=America/Halifax:20250219T160000
DTSTAMP:20260404T084101
CREATED:20241027T123535Z
LAST-MODIFIED:20250608T090136Z
UID:10000062-1739808000-1739980800@oncodaily.com
SUMMARY:Frontiers Symposium on Transformation in Cancer Care Delivery
DESCRIPTION:Frontiers Symposium on Transformation in Cancer Care Delivery will be held from February 17-19\, 2025 at the Marriott Downtown City Creek in Salt Lake City\, Utah. \nThis Symposium will convene leaders\, innovators\, and practitioners from across the oncology field. This premier event will spotlight emerging models in cancer care that address the entire patient continuum—from screening and risk assessment to diagnosis\, treatment\, and survivorship. With a focus on transformative approaches\, the symposium will feature insightful presentations and dynamic discussions to advance frameworks aimed at improving cancer care and patient outcomes. \nParticipants will delve into essential areas such as early detection gaps\, precise risk assessment\, treatment innovations\, and survivorship care. This event provides a collaborative platform for oncology professionals to explore and contribute to the next phase of cancer care\, offering an invaluable opportunity for thought exchange among top minds in the field. \n 
URL:https://oncodaily.com/event/173723
LOCATION:Salt Lake Marriott Downtown at City Creek\, 75 South West Temple Street\, Salt Lake City\, Utah\, 84101\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/Untitled-177.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250215
DTEND;VALUE=DATE:20250216
DTSTAMP:20260404T084101
CREATED:20250114T173106Z
LAST-MODIFIED:20250608T090148Z
UID:10000119-1739577600-1739663999@oncodaily.com
SUMMARY:Second Global Oncothon
DESCRIPTION:OncoDaily\, in partnership with the International Society of Pediatric Oncology (SIOP)\, is excited to announce the Second Global OncoThon\, a 24-hour virtual event aimed at raising vital funds and awareness for pediatric cancer research. Set to take place on February 15\, 2025\, in honor of Childhood Cancer Awareness Day\, this global telethon will bring together individuals and organizations from around the world to work toward a common goal: ensuring every child has the opportunity for a cancer-free future. \nChildhood cancer remains one of the leading causes of death by disease in children aged 1 to 19. Unfortunately\, there are significantly fewer drugs approved for pediatric cancer compared to over 200 approved for adults. Each year\, nearly half a million children are diagnosed with cancer\, and hundreds of thousands of lives are lost globally. Despite this\, childhood cancer is still classified as a rare disease. The pharmaceutical industry and venture capitalists often show limited interest in supporting initiatives beyond academic research due to the smaller market size of pediatric cancer compared to adult cancers. Without industry leadership\, the approval of new drugs for pediatric cancer becomes nearly impossible. \nThis event will be a day dedicated to connection\, compassion\, and action. It provides an opportunity for everyone to unite and declare that no child should ever have to face cancer alone. The Second Global OncoThon is our moment to inspire change and push for the breakthroughs that every child deserves.
URL:https://oncodaily.com/event/215646
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/WhatsApp-Image-2024-12-29-at-22.50.09.jpeg
ORGANIZER;CN="OncoDaily":MAILTO:info@oncodaily.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Denver:20250213T070000
DTEND;TZID=America/Denver:20250215T153000
DTSTAMP:20260404T084101
CREATED:20241008T172003Z
LAST-MODIFIED:20250713T084048Z
UID:10000019-1739430000-1739633400@oncodaily.com
SUMMARY:ASCO Genitourinary Cancers Symposium 2025
DESCRIPTION:The 2025 ASCO Genitourinary Cancers Symposium will take place from February 13-15 at Moscone West in San Francisco. \nThis event will showcase the latest research and best practices in GU cancer care\, featuring expert talks and engaging discussions. Attendees can expect a comprehensive program that includes keynote presentations\, panel discussions\, and interactive sessions focused on advancements in diagnosis\, treatment\, and patient management for GU cancers. \nThis is an invaluable opportunity for healthcare professionals to engage with leading researchers\, gain insights into emerging therapies\, and enhance their clinical practice. The symposium is co-sponsored by the American Society of Clinical Oncology\,  the American Society for Radiation Oncology and the Society of Urologic Oncology. \nRegister in-person or online for this opportunity to connect with leaders in the field and learn about cutting-edge treatments and strategies. \nFind more information about ASCO at OncoDaily.com.
URL:https://oncodaily.com/event/160386
LOCATION:Moscone West\, 800 Howard Street\, San Francisco\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/slider-5-slide-1.jpg
ORGANIZER;CN="American Society of Clinical Oncology":MAILTO:https://asco.org/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20250206T000000
DTEND;TZID=Europe/Helsinki:20250208T000000
DTSTAMP:20260404T084101
CREATED:20241025T133412Z
LAST-MODIFIED:20250608T090205Z
UID:10000058-1738800000-1738972800@oncodaily.com
SUMMARY:EHA-EBMT 7th European CAR T-cell Meeting
DESCRIPTION:EHA-EBMT 7th European CAR T-cell Meeting will be held from 6 February 2025 – 8 February 2025\, at Strasbourg\, France. \nThe meeting will cover a broad range of topics in CAR T-cell therapy\, including the latest unpublished clinical data\, advancements in manufacturing\, toxicity modeling\, CAR design\, and delivery methods. Participants will explore novel applications of CAR T-cell therapy and hear from leading experts in the field. It’s an excellent opportunity to stay updated on cutting-edge research and connect with peers and professionals driving innovation in CAR T-cell therapy. \nFor Registration Visit Here.
URL:https://oncodaily.com/event/170129
LOCATION:Palais de la Musique et des Congrès\, Place de Bordeaux\, Strasbourg\, 67000\, France
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/02/IMG_7459.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250204T160000
DTEND;TZID=America/Halifax:20250204T180000
DTSTAMP:20260404T084101
CREATED:20241206T192313Z
LAST-MODIFIED:20250608T090159Z
UID:10000093-1738684800-1738692000@oncodaily.com
SUMMARY:International Childhood Cancer Day 2025 by SIOP Europe
DESCRIPTION:International Childhood Cancer Day 2025 by SIOP Europe will be held at February 4th\, 2025 at European Parliament\, Brussels. \nThe International Children Cancer Day 2025 conference focuses on the theme “Cross-Border Access to Care\, Research\, and Training: Reducing Inequalities for Children with Cancer.” Building on the insights gathered from the previous year\, the second phase of the campaign aims to shift towards actionable solutions to address the challenges faced by children with cancer worldwide. \nThe conference will delve into collaborative efforts and initiatives emerging from different regions to improve access to care\, research\, and training for pediatric cancer. Key discussions will highlight innovative measures and successful models aimed at overcoming barriers such as limited healthcare infrastructure\, lack of access to treatment\, and disparities in medical training. \nThis year’s focus is on fostering global collaboration and knowledge exchange\, creating a platform where experts\, healthcare providers\, researchers\, and advocacy groups can share best practices\, policy recommendations\, and innovative solutions that have been implemented across various regions to tackle inequities in cancer care for children. The aim is to work collectively to reduce inequalities and ensure that every child has access to the best possible care\, research\, and training opportunities\, regardless of geographical location.
URL:https://oncodaily.com/event/198989
LOCATION:European Parliament\, Brussels\, Rue Wiertz 60\, 1050 Ixelles\, Brussels\, Belgium
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/1733413960623-1-e1733512909724.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250204
DTEND;VALUE=DATE:20250205
DTSTAMP:20260404T084101
CREATED:20250131T081054Z
LAST-MODIFIED:20250608T081941Z
UID:10000125-1738627200-1738713599@oncodaily.com
SUMMARY:World Cancer Day
DESCRIPTION:World Cancer Day is observed annually on February 4 to raise awareness about cancer\, promote its prevention\, and inspire global action to tackle the growing cancer crisis. The day is coordinated by the Union for International Cancer Control (UICC). \nThe Origins of World Cancer Day \n\n\n\n\nWorld Cancer Day was established on 4 February 2000 during the World Summit Against Cancer for the New Millennium in Paris. The Paris Charter\, which emerged from this summit\, was designed to promote cancer research\, prevention\, patient services\, and awareness. It also aimed to rally global efforts to make progress in the fight against cancer. As part of the Charter’s initiatives\, World Cancer Day was adopted as a means to unite the global community in addressing the challenges posed by cancer. \n\n\n\n\nWhat do we know about World Cancer Day? \nUICC organizes World Cancer Day campaigns in three-year cycles\, allowing for a deeper exploration of each year’s theme to maximize its impact and drive meaningful change. The new theme for World Cancer Day 2025-2027\, “United by Unique\,” focuses on putting people at the center of cancer care and highlighting their individual stories in the conversation. \nThrough individual\, collective\, and governmental efforts\, World Cancer Day envisions a world where millions of cancer-related deaths are prevented\, and life-saving treatments are accessible to all\, regardless of who they are or where they live. Every year\, numerous activities and events take place across the globe\, bringing communities\, organizations\, and individuals together in various settings—from schools to hospitals\, businesses\, parks\, and places of worship\, both offline and online. These events serve as a powerful reminder that everyone has a part to play in reducing the global burden of cancer.
URL:https://oncodaily.com/event/235054
LOCATION:WorldWide
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/01/IMG_7398.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Athens:20250203T090000
DTEND;TZID=Europe/Athens:20250205T150000
DTSTAMP:20260404T084101
CREATED:20241227T175119Z
LAST-MODIFIED:20250608T081959Z
UID:10000111-1738573200-1738767600@oncodaily.com
SUMMARY:9th Annual ELLOK Conference
DESCRIPTION:The 9th Annual ELLOK Conference will take place from February 3rd to 5th\, 2025\, at the Wyndham Grand Athens Hotel. \nThe event is organized by Hellenic Cancer Federation (ELLOK) and the theme of this year’s conference is “From Planning to Implementation”. This annual event is strategically aligned with World Cancer Day on February 4th\, providing a platform to address critical health policy issues and explore developments that impact the quality of oncology care and services. The conference will bring together a wide range of stakeholders\, including policymakers\, healthcare professionals\, patient organizations\, and industry representatives\, to engage in discussions that will shape the future of cancer care both in Greece and globally. \nThe 9th ELLOK Conference will serve as the launch event for the Union for International Cancer Control (UICC)’s three-year global campaign\, “United by Unique” (2025–2027). This campaign emphasizes the importance of collective efforts in cancer control while also celebrating the individuality of patient experiences and contributions to advocacy. \nThe purpose of the conference is to address critical concerns in oncology care\, such as improving patient access to innovative treatments\, advancing policy\, and promoting multidisciplinary approaches to care. Experts from various fields – including policymakers\, academia\, the scientific community\, healthcare professionals\, industry leaders\, and patient organizations – will gather to exchange insights and collaborate on developing effective strategies. With a focus on both theoretical frameworks and practical applications\, the conference aims to drive meaningful change in oncology care at both the national and European levels. \nRegistration is open for the event.
URL:https://oncodaily.com/event/214201
LOCATION:Wyndham Grand Athens Hotel\, Meg. Alexandrou 2\, Athina\, Athens\, 10437\, Greece
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/ELLOK.jpeg
ORGANIZER;CN="Hellenic Cancer Federation (ELLOK)":MAILTO:info@ellok.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250201T000000
DTEND;TZID=America/Halifax:20250204T000000
DTSTAMP:20260404T084101
CREATED:20241217T163617Z
LAST-MODIFIED:20250608T082009Z
UID:10000106-1738368000-1738627200@oncodaily.com
SUMMARY:AACR Special Conference in Cancer Research: DNA Methylation\, Clonal Hematopoiesis\, and Cancer
DESCRIPTION:AACR Special Conference in Cancer Research: DNA Methylation\, Clonal Hematopoiesis\, and Cancer will be held from February 1-4\, 2025. \nThe upcoming AACR Special Conference\, chaired by Stephen Baylin\, Margaret Goodell\, and Peter Jones will focus on the pivotal role of DNA methylation in human cancer\, celebrating the 25th Anniversary of the groundbreaking 1999 AACR Special Conference on “DNA Methylation\, Imprinting\, and the Epigenetics of Cancer.” This conference aims to spotlight recent research advances in the field of DNA methylation\, which has emerged as a central mechanism in cancer biology. It will emphasize the significance of DNA methylation specifically\, rather than covering broader chromatin biology topics like histone modifications. \nThe conference will provide extensive opportunities for presentation\, particularly for highly-rated abstracts\, with podium presentations\, plenary sessions\, and “lightning” talks scheduled before each poster session. Researchers\, clinicians\, and scientists will gather in San Diego for this exciting event\, which promises to offer valuable insights into the molecular underpinnings of cancer and the therapeutic potential of DNA methylation-based approaches. \nAdvance Registration Deadline is December 20th. \n 
URL:https://oncodaily.com/event/207579
LOCATION:The Westin San Diego Gaslamp Quarter\, 910 Broadway Cir\, San Diego\, CA\, San Diego\, CA\, 92101\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/Ge77HYoXIAAo0Tj.jpg
ORGANIZER;CN="American Association for Cancer Research":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250201T000000
DTEND;TZID=America/Halifax:20250203T000000
DTSTAMP:20260404T084101
CREATED:20241206T195928Z
LAST-MODIFIED:20250608T082016Z
UID:10000094-1738368000-1738540800@oncodaily.com
SUMMARY:13th AACR-JCA Joint Conference
DESCRIPTION:13th AACR-JCA Joint Conference will be held from February 1-3\, 2025 at Maui\, Hawaii. \nThe 13th AACR-JCA Joint Conference is a significant event hosted by the American Association for Cancer Research (AACR) in collaboration with the Japanese Cancer Association (JCA). This conference has a longstanding tradition of bringing together top cancer researchers from the United States\, Japan\, and around the world to share groundbreaking findings and discuss the latest advancements in basic\, translational\, and clinical cancer research. \nThe event aims to foster both formal and informal interactions among scientists and healthcare professionals\, promoting international collaborations in the field of cancer research. It provides a unique platform for investigators at all career stages to engage with the most current research developments\, share ideas\, and collaborate on new approaches to cancer treatment and prevention. \nJust like its previous editions\, the conference will present a comprehensive overview of contemporary cancer research\, addressing critical issues across various disciplines. Participants can expect to explore cutting-edge topics\, exchange knowledge\, and expand their networks\, contributing to the advancement of cancer research globally. \nRegistration is Open until December 20\, 2024.
URL:https://oncodaily.com/event/199008
LOCATION:Hyatt Regency Maui\, 200 Nohea Kai Dr\, Lahaina\, HI\, Maui\, Hawaii\, 96761\, United States
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/12/Screenshot-260-e1733515086197.png
ORGANIZER;CN="American Association for Cancer Research":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250129T180000
DTEND;TZID=America/Halifax:20250129T210000
DTSTAMP:20260404T084101
CREATED:20250113T170456Z
LAST-MODIFIED:20250608T082151Z
UID:10000117-1738173600-1738184400@oncodaily.com
SUMMARY:Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond by SPCC
DESCRIPTION:Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond by SPCC will be held at January 29th\, 2025 at 6 pm. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\nThe Outlook for the HR+/HER2- MBC Treatment Landscape in 2025 and Beyond Live Webinar will focus on the latest advancements and future directions in treating HR+ HER2- metastatic breast cancer (MBC). Experts will review recent clinical trial data\, discuss the current treatment landscape\, and explore the role of novel therapies\, including CDK4/6 inhibitors\, PI3K inhibitors\, and targeted therapies. The evolving landscape will also include next-generation treatments that could reshape patient care in the coming years. \nBiomarker testing plays a central role in guiding treatment decisions for HR+ HER2- MBC\, and the conference will cover how genomic tests and liquid biopsies\, such as ctDNA\, can help personalize therapies. A discussion will also take place on the balance between biomarker-driven therapies versus non-biomarker approaches\, addressing when and how each strategy should be utilized in clinical practice. \nThe conference will also focus on optimizing treatment sequencing based on clinical characteristics such as tumor burden\, mutational status\, and patient performance. Esteemed speakers include Dr. Martin Miguel (Hospital General Universitario Gregorio Marañón\, Spain)\, Dr. Neven Patrick (Universitaire Ziekenhuizen Leuven\, Belgium)\, and Dr. Joyce O’Shaughnessy (Baylor-Sammons Cancer Center\, USA)\, who will share their expertise on the latest research and treatment strategies for HR+ HER2- MBC.
URL:https://oncodaily.com/event/222894
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/01/WhatsApp-Image-2025-01-12-at-16.20.43.jpeg
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Denver:20250126T180000
DTEND;TZID=America/Denver:20250129T130000
DTSTAMP:20260404T084101
CREATED:20241008T195536Z
LAST-MODIFIED:20250608T082146Z
UID:10000023-1737914400-1738155600@oncodaily.com
SUMMARY:AACR Conference on Translating Targeted Therapies in Combination with Radiotherapy
DESCRIPTION:The AACR Special Conference in Cancer Research: Translating Targeted Therapies in Combination with Radiotherapy\, will be taking place at the Hilton San Diego Bayfront\, on January 26-29\, 2025. This conference will explore the future of radiation therapy\, focusing on innovative areas like heavy ion therapy\, FLASH radiation\, and the synergy between radiation and targeted therapies. \nThis event is organized by the American Association for Cancer Research. It’s an exciting opportunity to learn how these advancements can personalize cancer treatment and improve long-term outcomes for patients. \nDon’t miss your chance to be part of this transformative event in San Diego!
URL:https://oncodaily.com/event/160878
LOCATION:Hilton San Diego Bayfront\, 1 Park Blvd\, San Diego\, CA\, 92101\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/GZDiek2X0AA4etg.jpg
ORGANIZER;CN="American Association for Cancer Research":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Cairo:20250124T080000
DTEND;TZID=Africa/Cairo:20250125T203000
DTSTAMP:20260404T084101
CREATED:20250121T201151Z
LAST-MODIFIED:20250608T082141Z
UID:10000120-1737705600-1737837000@oncodaily.com
SUMMARY:The Breathe for Hope Conference
DESCRIPTION:The Breathe for Hope Conference is a pioneering event that combines the expertise of the Oncothoracic International Cancer Association (OnTIC) and the Onco-Bronchology International Conference (OncoBroncho). Scheduled to take place on 24-25 January 2025 at the prestigious Hilton Cairo Heliopolis\, this conference is designed to bring together leading professionals\, researchers\, and clinicians from across the globe to explore the latest advancements in oncology and lung health. The event will serve as a platform to share cutting-edge research\, discuss innovative treatment strategies\, and collaborate on future directions in the fight against lung cancer and other thoracic diseases. \nAttendees can expect to engage in thought-provoking discussions\, attend workshops\, and hear from experts on various topics\, from the latest molecular treatments to groundbreaking techniques in bronchoscopy and thoracic surgery. This conference represents an exciting opportunity to be at the forefront of cancer research and treatment\, as experts come together to push the boundaries of what’s possible in improving patient outcomes. \nRegisteration is Open for the Event.
URL:https://oncodaily.com/event/228785
LOCATION:the Hilton Heliopolis Hotel in Cairo\, Egypt\, El-Orouba\, Sheraton Al Matar\, El Nozha\, Cairo Governorate\, El Nozha\, Cairo\, Al\, Egypt
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/01/WhatsApp-Image-2025-01-21-at-11.22.43.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250123T150000
DTEND;TZID=America/Halifax:20250123T170000
DTSTAMP:20260404T084101
CREATED:20241217T191048Z
LAST-MODIFIED:20250608T082132Z
UID:10000107-1737644400-1737651600@oncodaily.com
SUMMARY:HEAL webinar series on the health impacts of per- and polyfluoroalkyl substances
DESCRIPTION:HEAL webinar series on the health impacts of per- and polyfluoroalkyl substances will be held on 23 January 2024 at 15:00 CET. \nThe HEAL Virtual Webinar Series on PFAS and Human Health is a crucial initiative aimed at raising awareness about the health impacts of PFAS (Per- and Polyfluoroalkyl Substances). These chemicals\, widely used in consumer products\, have been linked to various health concerns\, including immune system disruption\, cancer\, and developmental issues. The series invites leading experts to discuss the health effects of PFAS exposure\, with each webinar focusing on different aspects of this growing issue. The series aims to inform the public and policymakers on the importance of addressing PFAS contamination and its long-term health implications. \nOrganized in partnership with the Association of European Cancer Leagues (ECL)\, this session will explore the links between PFAS and cancer\, considering the evaluation from the International Agency for Research on Cancer (IARC) and supporting epidemiological studies. The webinar will feature Dr. Tony Fletcher\, an Associate Professor at the London School of Hygiene and Tropical Medicine\, who has led research on PFAS exposure in communities in Ronneby\, Sweden\, and Veneto\, Italy. His research has contributed to understanding the carcinogenic potential of PFAS and its widespread health risks. \nThis webinar is part of a broader effort to educate and raise awareness about the dangers of PFAS exposure. Recordings of previous webinars\, including topics on the immune system and the effects of early-life exposure to PFAS\, will also be made available for those who wish to catch up on the ongoing discussion. The series serves as a critical platform for sharing the latest scientific findings and fostering discussions on how to mitigate the health risks associated with these harmful substances. \nRegistration is Open.
URL:https://oncodaily.com/event/207626
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/12/PFAS-Webinar-series-X-7.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Denver:20250123T073000
DTEND;TZID=America/Denver:20250125T160000
DTSTAMP:20260404T084101
CREATED:20241007T155451Z
LAST-MODIFIED:20250713T084159Z
UID:10000014-1737617400-1737820800@oncodaily.com
SUMMARY:ASCO Gastrointestinal Cancers Symposium 2025
DESCRIPTION:The ASCO Gastrointestinal Cancers 2025 Symposium\, happening on January 23-25 in Moscone West\, San Francisco\, will bring together top experts in gastrointestinal oncology. Attendees can look forward to insightful keynote talks\, engaging panel discussions\, and the latest research on treatments and diagnostics for gastrointestinal cancers. \nThe event will also showcase poster presentations from emerging researchers\, offering great networking opportunities for everyone involved. \nThe Co-Organizers of the symposium are the American Society of Clinical Oncology\, the American Gastroenterological Association\, the American Society for Radiation Oncology and the Society of Surgical Oncology. \nThis symposium is a must-attend for anyone interested in the latest trends and innovations in the field\, as it will play a vital role in shaping the future of patient care in gastrointestinal oncology. \nRegister here.
URL:https://oncodaily.com/event/159556
LOCATION:Moscone West\, 800 Howard Street\, San Francisco\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/asco.jpg
ORGANIZER;CN="American Society of Clinical Oncology":MAILTO:https://asco.org/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Cairo:20250123T000000
DTEND;TZID=Africa/Cairo:20250124T000000
DTSTAMP:20260404T084101
CREATED:20241219T143049Z
LAST-MODIFIED:20250608T082123Z
UID:10000098-1737590400-1737676800@oncodaily.com
SUMMARY:The 17th BGICC 2025
DESCRIPTION:The 17th BGICC 2025 (Breast\, Gynecological and Immuno-oncology International Cancer Conference) is a premier event in the field of oncology\, widely recognized as the largest and most prestigious cancer conference in both Africa and the Middle East. Scheduled to take place from January 23-24\, 2025\, at the Hilton Heliopolis Hotel in Cairo\, Egypt\, this conference serves as a hub for oncology professionals\, researchers\, and clinicians to gather and share cutting-edge knowledge and advancements in cancer care and treatment. \nThe conference will feature a comprehensive agenda that includes high-level lectures\, interactive workshops\, and specialized courses\, providing participants with an opportunity to delve into the latest research and clinical practices in breast cancer\, gynecological oncology\, and immuno-oncology. The event aims to bridge the gap between scientific discovery and clinical application\, offering insights into innovative therapies\, emerging treatment protocols\, and the evolving landscape of cancer care. \nThe 17th BGICC 2025 is set to be led by some of the most esteemed experts in oncology. The course will be directed by Prof. Manal El Mahdy from Ain Shams University\, with Prof. Rouba Ali-Fehmi from the University of Michigan serving as the course co-director. These renowned experts will guide participants through discussions and sessions on the latest breakthroughs in cancer research and treatment. \nBy attending BGICC 2025\, participants will not only gain valuable knowledge but also network with leaders in the oncology field\, share ideas\, and collaborate on global efforts to advance cancer treatment and patient care. The conference promises to be an exciting and impactful event that will shape the future of oncology in the region and beyond. \nThe Abstract Submission Closes at December 29th. \nFor Registration\, visit here.
URL:https://oncodaily.com/event/200357
LOCATION:the Hilton Heliopolis Hotel in Cairo\, Egypt\, El-Orouba\, Sheraton Al Matar\, El Nozha\, Cairo Governorate\, El Nozha\, Cairo\, Al\, Egypt
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/Untitled-1755.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250123
DTEND;VALUE=DATE:20250124
DTSTAMP:20260404T084101
CREATED:20250123T185013Z
LAST-MODIFIED:20250608T082116Z
UID:10000121-1737590400-1737676799@oncodaily.com
SUMMARY:International BPDCN Day
DESCRIPTION:January 23rd of 2025 marks the International BPDCN Day. We unite to shed light on Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)\, a rare and aggressive hematologic malignancy that often remains underdiagnosed due to its rarity and complex presentation. \nWhat do we know about BPDCN?\nIn 2008\, BPDCN was recognized by the WHO as a distinct entity and separately listed in the group of acute myeloid leukemias and related precursor neoplasms. BPDCN predominantly affects the skin\, bone marrow\, and lymph nodes\, posing significant diagnostic and therapeutic challenges. Despite advances in hematology\, much remains to be understood about its pathogenesis\, optimal treatment strategies\, and long-term outcomes. Greater awareness and focused research are critical to improving the prognosis for patients worldwide. \nAt present\, there is no consensus on the optimal treatment of BPDCN. The majority of patients receive multi-agent chemotherapy with AML or ALL treatment regimens\, while a few patients undergo allogeneic hematopoietic stem cell transplantation (HSCT). Different novel and innovative therapies are in development to target surface molecules in BPDCN. However\, patients are still in need of better treatments and the optimal therapy for the disease remains to be determined. \nWhat can we do for patients diagnosed with BPDCN?\nUnfortunately\, projects devoted to this mission are not many either. The BPDCN International Registry is one of them\, aimed in building a large database of patients to investigate the characteristics and outcomes of the disease with different treatment regimens\, evaluate prognostic factors\, and generate data-based prospective treatment recommendations. \nLet’s unite on International BPDCN Day to amplify our collective efforts\, inspire new collaborations\, and give hope to patients and their families. Together\, we can make a meaningful difference in the fight against this disease.
URL:https://oncodaily.com/event/bpdcn-230151
LOCATION:WorldWide
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/01/IMG_6943-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250121T130000
DTEND;TZID=America/Halifax:20250121T143000
DTSTAMP:20260404T084101
CREATED:20250111T200927Z
LAST-MODIFIED:20250608T082110Z
UID:10000116-1737464400-1737469800@oncodaily.com
SUMMARY:Exploring a New Generation of Patient-Centric Cancer Clinical Trials by AACR
DESCRIPTION:Exploring a New Generation of Patient-Centric Cancer Clinical Trials by AACR will be held on January 21\, 2025\, Virtually. \nThe forum will explore the new generation of patient-centric cancer clinical trials\, focusing on how advancements in cancer research will reshape the clinical trial process. As more people are expected to survive and live beyond cancer\, largely due to clinical trials\, the conference will highlight the ongoing transformation in trial design. The emphasis will be on creating more efficient\, inclusive\, and patient-focused trials that prioritize patient needs and preferences. This shift will be critical in ensuring broader access to innovative treatments and improving overall patient outcomes. \nThe upcoming session will feature a group of esteemed experts in the field of cancer research. Jan Tomlinson from the University of California\, San Francisco\, will share insights from a patient advocate’s perspective on the clinical trial experience. Patricia M. LoRusso\, DO\, PhD (HC)\, FAACR\, from Yale Cancer Center\, will discuss innovative clinical trial designs aimed at improving efficiency and inclusivity. David A. Tuveson\, MD\, PhD\, FAACR\, from CSHL Cancer Center\, will highlight the Cancer Therapeutics Initiative\, which focuses on translating basic research into clinical applications. Laura van ‘t Veer\, PhD\, from the University of California\, San Francisco\, will present on the second-generation design of the I-SPY 2 trial\, driving advancements in precision medicine. These experts will cover a broad range of topics\, all geared toward advancing cancer clinical trials and patient care. \nRegister Now!
URL:https://oncodaily.com/event/221654
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/01/1736108582473-e1736625939487.jpg
ORGANIZER;CN="American Association for Cancer Research":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Hong_Kong:20250115T140000
DTEND;TZID=Asia/Hong_Kong:20250115T160000
DTSTAMP:20260404T084101
CREATED:20250106T184225Z
LAST-MODIFIED:20250608T082104Z
UID:10000114-1736949600-1736956800@oncodaily.com
SUMMARY:2025 CACA-OncoDaily-SPCC Cancer Summit: Bridging Continents
DESCRIPTION:The Cancer Summit\, organized by the China Anti-Cancer Association (CACA)\, OncoDaily\, Sharing Progress in Cancer Care (SPCC)\, and the World Association for Integrative Oncology (WAIO)\, will take place on January 15\, 2025 via Zoom and will feature simultaneous translation in English and Chinese. \nThe summit will be held at the following times: \n\nChina Standard Time: 02:00-04:00pm\nUS EST: 01:00-03:00am\nCentral European Time: 07:00-09:00am\n\nThe event highlights the crucial rule of collaboration in tackling the current challenges faced in oncology. \nRead more about the event here.
URL:https://oncodaily.com/event/caca-oncodaily-spcc-cancer-summit218610
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/01/5.1-2025-CACA-Oncodaily-SPCC-Cancer-Summit-Poster.jpg
ORGANIZER;CN="the China Anti-Cancer Association (CACA)":MAILTO:intl@caca.org.cn
LOCATION:
END:VEVENT
END:VCALENDAR